[µ¿¿µ»ó¾÷·Îµå] Lentivi & AAV Transfection Platforms for Gene Therapy
Transfection Àü¹®±â¾÷ Mirus¿¡¼ ÁøÇàÇÑ
¡®How LV and AAV Transfection Platforms will Shape the Future of Gene Therapy Manufacturing¡¯ webinar µ¿¿µ»óÀ»
Áö±Ý, ´ÙÄ«¶óÄÚ¸®¾Æ ȨÆäÀÌÁö¿¡¼ È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
[Mirus] Transfection for Virus production webinar µ¿¿µ»ó º¸·¯°¡±â (¸µÅ©)
Learning Objectives:
- Introduce TransIT-VirusGEN¢ç LV and AAV Kits for development and manufacture of Cell and Gene Therapies
- Understand the need for increasing manufacturing efficiency to generate sufficient doses for large patient populations
- Highlight the TransIT-VirusGEN¢ç SELECT and upcoming GMP Products and quality control documentation
- Demonstrate critical parameters for optimized virus production using TransIT-VirusGEN¢ç Reagent and Kits
±× ¿Ü ¹®ÀÇ»çÇ×Àº °í°´Áö¿ø¼¾ÅÍ (02-2081-2510, support@takara.co.kr) ·Î ¿¬¶ô¹Ù¶ø´Ï´Ù.
°¨»çÇÕ´Ï´Ù.